Clinical Trial Update: Atomoxetine/Attention Deficit/ Hyperactive Disorder (ADHD)/Substance Use Disorder (SUD)in a Residential Treatment Facility [NA]

View source ↗

Summary

Completed clinical trial evaluating atomoxetine for Attention Deficit Hyperactivity Disorder in individuals with Substance Use Disorder in a residential treatme…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Attention Deficit Hyperactivity Disorder
• Substance Use Disorder

Drugs mentioned

• Atomoxetine (Atomoxetine)

Snippet

Sponsor: NYU Langone Health | Conditions: Attention Deficit Hyperactivity Disorder | NA | Status: COMPLETED | Results posted: 2016-03-28